Picture of Alivus Life Sciences logo

ALIVUS — Alivus Life Sciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Brief: Glenmark Says Entered Into Letter Agreement With Glenmark Pharmaceuticals And Nirma

July 4 (Reuters) - Glenmark Life Sciences Ltd  GLEM.NS :
    * GLENMARK - ENTERED INTO A LETTER AGREEMENT WITH GLENMARK
PHARMACEUTICALS AND NIRMA
    * GLENMARK LIFE - AGREEMENT AMENDS EARLIER SHARE PURCHASE
AGREEMENT
    * GLENMARK LIFE - AGREEMENT HAS WAIVED CONTRACTUAL
RESTRICTION
IMPOSED ON SELLER
    * GLENMARK LIFE - IF SELLER IS NOT ABLE TO COMPLETE SALE OF
SHAREHOLDING, RESTRICTIONS SHALL BE REINSTATED
    * GLENMARK LIFE - RESTRICTION WAIVED TO FACILITATE
COMPLIANCE WITH
MINIMUM PUBLIC SHAREHOLDING REQUIREMENTS

Source text for Eikon:  ID:nBSE3XqBzS 
Further company coverage:  GLEM.NS 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Alivus Life Sciences

See all news